BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19307728)

  • 21. Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells.
    Schaniel C; Sirabella D; Qiu J; Niu X; Lemischka IR; Moore KA
    Blood; 2011 Sep; 118(9):2420-9. PubMed ID: 21652676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
    Chim CS; Pang R; Fung TK; Choi CL; Liang R
    Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
    Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
    Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
    Tang Y; Simoneau AR; Liao WX; Yi G; Hope C; Liu F; Li S; Xie J; Holcombe RF; Jurnak FA; Mercola D; Hoang BH; Zi X
    Mol Cancer Ther; 2009 Feb; 8(2):458-68. PubMed ID: 19174556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
    Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
    Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide exhibits antitumor effects by reversing hypermethylation of WIF‑1 in lung cancer cells.
    Mao X; Tong J; Wang Y; Zhu Z; Yin Y; Wang Y
    Mol Med Rep; 2018 Sep; 18(3):3041-3049. PubMed ID: 30015908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WIF1 can effectively co-regulate pro-apoptotic activity through the combination with DKK1.
    Ko YB; Kim BR; Yoon K; Choi EK; Seo SH; Lee Y; Lee MA; Yang JB; Park MS; Rho SB
    Cell Signal; 2014 Nov; 26(11):2562-72. PubMed ID: 25086206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad1 and its target gene Wif1 coordinate BMP and Wnt signaling activities to regulate fetal lung development.
    Xu B; Chen C; Chen H; Zheng SG; Bringas P; Xu M; Zhou X; Chen D; Umans L; Zwijsen A; Shi W
    Development; 2011 Mar; 138(5):925-35. PubMed ID: 21270055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer.
    Alvarez C; Tapia T; Cornejo V; Fernandez W; Muñoz A; Camus M; Alvarez M; Devoto L; Carvallo P
    Mol Carcinog; 2013 Jun; 52(6):475-87. PubMed ID: 22315090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.
    Batra S; Shi Y; Kuchenbecker KM; He B; Reguart N; Mikami I; You L; Xu Z; Lin YC; Clément G; Jablons DM
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1228-32. PubMed ID: 16516163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
    Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.
    Yee DS; Tang Y; Li X; Liu Z; Guo Y; Ghaffar S; McQueen P; Atreya D; Xie J; Simoneau AR; Hoang BH; Zi X
    Mol Cancer; 2010 Jun; 9():162. PubMed ID: 20573255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
    Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
    Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins.
    Huang Y; Du Q; Wu W; She F; Chen Y
    Mol Med Rep; 2016 Sep; 14(3):2573-81. PubMed ID: 27430608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
    Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
    Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts.
    Vaes BL; Dechering KJ; van Someren EP; Hendriks JM; van de Ven CJ; Feijen A; Mummery CL; Reinders MJ; Olijve W; van Zoelen EJ; Steegenga WT
    Bone; 2005 May; 36(5):803-11. PubMed ID: 15820155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt signaling as a therapeutic target for bone diseases.
    Hoeppner LH; Secreto FJ; Westendorf JJ
    Expert Opin Ther Targets; 2009 Apr; 13(4):485-96. PubMed ID: 19335070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
    Vaidya H; Rumph C; Katula KS
    PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.